Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS

Neuroscience Research

Volumn 59, Issue 4, 2007, Pages 446-456

  Kadoyama, Keiichi ^a   Funakoshi, Hiroshi ^a   Ohya, Wakana ^a   Nakamura, Toshikazu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

c Met; Caspases; Microglia; Monocyte chemoattractant protein 1 (MCP 1); X chromosome linked inhibitor of apoptosis protein (XIAP)

Indexed keywords

CASPASE 3 INHIBITOR; CASPASE 9; INTERLEUKIN 1BETA CONVERTING ENZYME; MONOCYTE CHEMOTACTIC PROTEIN 1; SCATTER FACTOR; X LINKED INHIBITOR OF APOPTOSIS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; GLIOSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOTONEURON NUCLEUS; MOUSE; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; APOPTOSIS REGULATORY PROTEINS; ASTROCYTES; BRAIN STEM; CHEMOKINE CCL2; CRANIAL NERVES; DISEASE MODELS, ANIMAL; FEMALE; GLIOSIS; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; MOTOR NEURONS; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME;

EID: 35549010204     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2007.08.017     Document Type: Article

References (53)

1. Azzouz M., Ralph G.S., Storkebaum E., Walmsley L.E., Mitrophanous K.A., Kingsman S.M., Carmeliet P., and Mazarakis N.D. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429 (2004) 413-417
2. Baron P., Bussini S., Cardin V., Corbo M., Conti G., Galimberti D., Scarpini E., Bresolin N., Wharton S.B., Shaw P.J., and Silani V. Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis. Muscle Nerve 32 (2005) 541-544
3. Berman J.W., Guida M.P., Warren J., Amat J., and Brosnan C.F. Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J. Immunol. 156 (1996) 3017-3023
4. Boillee S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., and Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312 (2006) 1389-1392
5. Calingasan N.Y., Chen J., Kiaei M., and Beal M.F. ß-Amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients. Neurobiol. Dis. 19 (2005) 340-347
6. Cleveland D.W., and Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2 (2001) 806-819
7. Deveraux Q.L., Takahashi R., Salvesen G.S., and Reed J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388 (1997) 300-304
8. Di Giorgio F.P., Carrasco M.A., Siao M.C., Maniatis T., and Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat. Neurosci. 10 (2007) 608-614
9. Ebens A., Brose K., Leonardo E.D., Hanson Jr. M.G., Bladt F., Birchmeier C., Barres B.A., and Tessier-Lavigne M. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron 17 (1996) 1157-1172
10. Friedlander R.M., Brown R.H., Gagliardini V., Wang J., and Yuan J. Inhibition of ICE slows ALS in mice. Nature 388 (1997) 31
11. Funakoshi H., Belluardo N., Arenas E., Yamamoto Y., Casabona A., Persson H., and Ibanez C.F. Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science 268 (1995) 1495-1499
12. Funakoshi H., Risling M., Carlstedt T., Lendahl U., Timmusk T., Metsis M., Yamamoto Y., and Ibanez C.F. Targeted expression of a multifunctional chimeric neurotrophin in the lesioned sciatic nerve accelerates regeneration of sensory and motor axons. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 5269-5274
13. Funakoshi H., and Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications. Clin. Chim. Acta 327 (2003) 1-23
14. Giulian D., Woodward J., Young D.G., Krebs J.F., and Lachman L.B. Interleukin-1 injected into mammalian brain stimulates astrocytosis and neovascularization. J. Neurosci. 8 (1988) 2485-2490
15. Gong R., Rifai A., Tolbert E.M., Biswas P., Centracchio J.N., and Dworkin L.D. Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES. J. Am. Soc. Nephrol. 15 (2004) 2868-2881
16. Guegan C., Vila M., Rosoklija G., Hays A.P., and Przedborski S. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J. Neurosci. 21 (2001) 6569-6576
17. Guillot S., Azzouz M., Deglon N., Zurn A., and Aebischer P. Local GDNF expression mediated by lentiviral vector protects facial nerve motor neurons but not spinal motor neurons in SOD1(G93A) transgenic mice. Neurobiol. Dis. 16 (2004) 139-149
18. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., Chen W., Zhai P., Sufit R.L., and Siddique T. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
19. Henkel J.S., Engelhardt J.I., Siklos L., Simpson E.P., Kim S.H., Pan T., Goodman J.C., Siddique T., Beers D.R., and Appel S.H. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol. 55 (2004) 221-235
20. Henkel J.S., Beers D.R., Siklos L., and Appel S.H. The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol. Cell. Neurosci. 31 (2006) 427-437
21. Herx L.M., and Yong V.W. Interleukin-1ß is required for the early evolution of reactive astrocytosis following CNS lesion. J. Neuropathol. Exp. Neurol. 60 (2001) 961-971
22. Honda S., Kagoshima M., Wanaka A., Tohyama M., Matsumoto K., and Nakamura T. Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: implication as neurotrophic factor. Brain Res. Mol. Brain Res. 32 (1995) 197-210
23. Ilzecka J., Stelmasiak Z., and Dobosz B. Interleukin-1ß converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients. Acta Neurol. Scand. 103 (2001) 255-258
24. Imai Y., Ibata I., Ito D., Ohsawa K., and Kohsaka S. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem. Biophys. Res. Commun. 224 (1996) 855-862
25. Inoue H., Tsukita K., Iwasato T., Suzuki Y., Tomioka M., Tateno M., Nagao M., Kawata A., Saido T.C., Miura M., Misawa H., Itohara S., and Takahashi R. The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model. EMBO J. 22 (2003) 6665-6674
26. Jiang Y.M., Yamamoto M., Kobayashi Y., Yoshihara T., Liang Y., Terao S., Takeuchi H., Ishigaki S., Katsuno M., Adachi H., Niwa J., Tanaka F., Doyu M., Yoshida M., Hashizume Y., and Sobue G. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann. Neurol. 57 (2005) 236-251
27. John G.R., Chen L., Rivieccio M.A., Melendez-Vasquez C.V., Hartley A., and Brosnan C.F. Interleukin-1ß induces a reactive astroglial phenotype via deactivation of the Rho GTPase-Rock axis. J. Neurosci. 24 (2004) 2837-2845
28. Kaspar B.K., Llado J., Sherkat N., Rothstein J.D., and Gage F.H. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301 (2003) 839-842
29. Kato S., Funakoshi H., Nakamura T., Kato M., Nakano I., Hirano A., and Ohama E. Expression of hepatocyte growth factor and c-Met in the anterior horn cells of the spinal cord in the patients with amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS and familial ALS with superoxide dismutase 1 gene mutation. Acta Neuropathol. 106 (2003) 112-120
30. Keep M., Elmer E., Fong K.S., and Csiszar K. Intrathecal cyclosporin prolongs survival of late-stage ALS mice. Brain Res. 894 (2001) 327-331
31. Kostic V., Jackson-Lewis V., de Bilbao F., Dubois-Dauphin M., and Przedborski S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277 (1997) 559-562
32. Kriz J., Nguyen M.D., and Julien J.P. Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 10 (2002) 268-278
33. Li M., Ona V.O., Guegan C., Chen M., Jackson-Lewis V., Andrews L.J., Olszewski A.J., Stieg P.E., Lee J.P., Przedborski S., and Friedlander R.M. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288 (2000) 335-339
34. Meeuwsen S., Persoon-Deen C., Bsibsi M., Ravid R., and van Noort J.M. Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia 43 (2003) 243-253
35. Morizane Y., Honda R., Fukami K., and Yasuda H. X-linked inhibitor of apoptosis functions as ubiquitin ligase toward mature caspase-9 and cytosolic Smac/DIABLO. J. Biochem. (Tokyo) 137 (2005) 125-132
36. Nagai M., Re D.B., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., and Przedorski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 10 (2007) 615-622
37. Nakamura T., Nawa K., and Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122 (1984) 1450-1459
38. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., Tashiro K., and Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature 342 (1989) 440-443
39. Novak K.D., Prevette D., Wang S., Gould T.W., and Oppenheim R.W. Hepatocyte growth factor/scatter factor is a neurotrophic survival factor for lumbar but not for other somatic motor neurons in the chick embryo. J. Neurosci. 20 (2000) 326-337
40. Pasinelli P., Houseweart M.K., Brown Jr. R.H., and Cleveland D.W. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu, Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 13901-13906
41. Pasinelli P., and Brown Jr. R.H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7 (2006) 710-723
42. Sakamoto T., Kawazoe Y., Shen J.S., Takeda Y., Arakawa Y., Ogawa J., Oyanagi K., Ohashi T., Watanabe K., Inoue K., Eto Y., and Watabe K. Adenoviral gene transfer of GDNF, BDNF and TGF beta 2, but not CNTF, cardiotrophin-1 or IGF1, protects injured adult motor neurons after facial nerve avulsion. J. Neurosci. Res. 72 (2003) 54-64
43. Sendtner M., Holtmann B., Kolbeck R., Thoenen H., and Barde Y.A. Brain-derived neurotrophic factor prevents the death of motor neurons in newborn rats after nerve section. Nature 360 (1992) 757-759
44. Shi Y. Caspase activation, inhibition, and reactivation: a mechanistic view. Protein Sci. 13 (2004) 1979-1987
45. Sun W., Funakoshi H., and Nakamura T. Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J. Neurosci. 22 (2002) 6537-6548
46. Thornberry N.A., Bull H.G., Calaycay J.R., Chapman K.T., Howard A.D., Kostura M.J., Miller D.K., Molineaux S.M., Weidner J.R., Aunins J., Elliston K.O., Ayala J.M., Casano F.J., Chin J., Ding G.J.F., Egger L.A., Gaffney E.P., Limjuco G., Palyha O.C., Raju S.M., Rolando A.M., Salley J.P., Yamin T.-T., Lee T.D., Shively J.E., MacCross M., Mumford R.A., Schmidt J.A., and Tocci M.J. A novel heterodimeric cysteine protease is required for interleukin-1ß processing in monocytes. Nature 356 (1992) 768-774
47. Van Den Bosch L., Tilkin P., Lemmens G., and Robberecht W. Minocycline delays disease onset and mortality in a transgenic model of ALS. Neuroreport 13 (2002) 1067-1070
48. Wang L.J., Lu Y.Y., Muramatsu S., Ikeguchi K., Fujimoto K., Okada T., Mizukami H., Matsushita T., Hanazono Y., Kume A., Nagatsu T., Ozawa K., and Nakano I. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J. Neurosci. 22 (2002) 6920-6928
49. Weydt P., Yuen E.C., Ransom B.R., and Moller T. Increased cytotoxic potential of microglia from ALS-transgenic mice. GLIA 48 (2004) 179-182
50. Xiao Q., Zhao W., Beers D.R., Yen A.A., Xie W., Henkel J.S., and Appel S.H. Mutant SOD1G93A microglia are more neurotoxic relative to wild-type microglia. J. Neurochem. 102 (2007) 2008-2019
51. Yamamoto Y., Livet J., Pollock R.A., Garces A., Arce V., deLapeyriere O., and Henderson C.E. Hepatocyte growth factor (HGF/SF) is a muscle-derived survival factor for a subpopulation of embryonic motor neurons. Development 124 (1997) 2903-2913
52. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., and Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 13496-13500
53. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y., Ona V., Li M., Sarang S., Liu A.S., Hartley D.M., Wu D.C., Gullans S., Ferrante R.J., Przedborski S., Kristal B.S., and Friedlander R.M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417 (2002) 74-78